Mr. Gerri Greenham reports

SOLARVEST BIOENERGY INC. INTENDS WARRANT EXTENSION

Solarvest Bioenergy Inc. intends to amend certain common share purchase warrants in the capital of the company, which were issued pursuant to a private placement in April, 2015.

Each warrant shall remain exercisable at 35 cents per share and the term shall be extended for an additional 12 months, such that 242,000 warrants shall be amended to expire Oct. 29, 2018.

The application to amend the warrants is subject to its acceptance by the TSX Venture Exchange and the company makes no assurances that the required acceptance for the extension of the term of the warrants will be accepted.

About Solarvest Bioenergy Inc.

Solarvest is an algae technology company that owns numerous key patents. Its organic Omega-3 patent is issued in Europe, the United Kingdom, the United States, Canada, Japan, India, China, South Korea, Hong Kong and Australia and is being defending in other significant countries. Its patented process produces the world's first organic DHA and EPA Omega-3 using algae. The company has been working with a contract manufacturer to achieve economic/commercial yields and is poised to supply the $25-billion global Omega-3 market.

We seek Safe Harbor.